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MEDICATION ADHERENCE PROTOCOL
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Identification of the Problem
The population of the United States is aging. It is estimated that by the year 2050,
one in five adults will be classified as elderly (Sandberg-Cook, 2014). As advances in
healthcare continue, more and more people are living with chronic illness (Wilper, et al.,
2008). Clinical management of chronic illness and disease often requires the prescription
of several medications that must be taken every day, often for the remainder of the
person’s life. For patients to obtain maximal benefit from these medications, they must be
taken exactly as prescribed.
Medication adherence has been defined as a patient taking prescribed medications
as directed by their prescribing healthcare provider (Morgan, et al., 2015). This is a
challenging aspect of healthcare provision because recent data demonstrates that only
50% of prescribed medications are taken as directed (WHO, 2013). This widespread
nonadherence is costly in terms of patient health as the effectiveness of treatments is
compromised leading to poor clinical outcomes for patients (Aggarwal, Pender, Mosca,
& Mochari-Greenberger, 2015). Another significant factor associated with medication
nonadherence is financial cost with an estimated $100 billion annually linked to
decreased adherence to prescribed medication regimens in the treatment of chronic illness
in the United States (van den Bemt, Zwikker, & van den Ende, 2012).
Medication nonadherence is a problem that is shared by patients, caregivers and
families, as well as healthcare providers in many settings (Zullig, Peterson, & Bosworth,
2013). The causes of patient medication nonadherence are complex and multifactorial
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and include cost of medications, patient assessment of benefits versus risks, as well as
understanding of efficacy of prescribed agents (Marcum, Sevick, & Handler, 2013).
Individual factors such as age, sex, financial resources, health literacy, and physical
limitations all impact a patients’ medication adherence behavior (Hearnshaw, et al.,
2006).
Researchers have looked at the problem in terms of two categories: intentional
and unintentional nonadherence, thus clinicians are challenged to consider patient
preferences and beliefs as a critical component of medication adherence (van den Bemt,
Zwikker, & van den Ende, 2012). Determining why a patient is not taking a medication is
often the key to addressing the underlying adherence issue (Conn, Ruppar, Enriquez, &
Cooper, 2015).
Clinical inertia surrounding medication nonadherence is yet another factor that
complicates the picture. Clinicians in all clinical settings must be vigilant about
promoting medication adherence but what is often seen is that, after a medication is
prescribed and initial education is given, no further followup regarding adherence is
given (Blackberry, Furler, Best, & Young, 2015).
It is clear that the problem of medication nonadherence is pervasive in terms of
poor patient outcomes. Extensive time and effort is invested, globally, in search of more
effective ways to manage diseases, and for many disorders we now have methods to
prevent occurrence (Kronish & Ye, 2013). Novel medication classes are being developed
to address some of the most devastating diseases that severely impact patient quality of
life (Morgan, et al., 2015). However, until clinicians are committed to working
collaboratively with patients in developing care plans that are congruent to the setting and
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desires of the patient, medication adherence will continue to be a rate-limiting step in the
arena of healthcare management.
Review of Literature
A review of current literature was conducted to look at the evidence for
developing interventions in the clinical setting to address medication nonadherence. An
initial search using the University of Alabama in Huntsville (UAH) Salmon Library and
the University of Alabama at Birmingham (UAB) Lister Library was done using the
following specific databases: CINAHL, PubMed, Medline, and the Cochrane Database.
Key search terms included medication, adherence, education, interventions, chronic
illness, strategies, and compliance. Boolean search terminology was incorporated into the
search to narrow the scope of the review. Limits were placed on language (English only),
peer-reviewed journal submissions, and year of publication. The initial search of the
UAH library yielded 572 results. The term patient education was added which lowered
the number of articles retrieved to 107. The abstracts of these 107 publications were
scanned for relevance to the proposed project.
The UAB literature search used the same key words/terms utilizing the PubMed
and Medline databases. The initial UAB search yielded 2,143 publications. Additional
filters were applied, such as free full text, and publication dates within the past five years.
At this point, 580 reports were retrieved. A further limitation on the search for clinical
trials brought the number down to 146 studies. The abstracts for these publications were
reviewed for relevance and, from these two libraries, a total of twenty-nine studies were
selected for analysis in terms of applicability for project development.
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Following completion of the implementation phase of the project, a further
literature review was conducted to look for recent publications and new evidence on the
topic since the initial searches were done. The above databases were searched using the
same search terms. From this further review, an additional twenty-four publications
provided further information on advances and research directions for medication
nonadherence.
The literature review revealed that, although a large body of research exists on the
topic of medication nonadherence, there remain few specific practice recommendations
with demonstrated efficacy. Common problems identified in the review included
inconsistency in terminology and taxonomy, incomplete descriptions of intervention
methodologies, small sample size, and lack of generalizability due to disease-specific
studies with a narrowed scope of interest (Haynes, Ackloo, Sahota, McDonald, & Yao,
2008).
Studies that evaluated the impact of interventions designed to improve adherence
behaviors were extremely diverse with very few strong recommendations elucidated
(Hearnshaw, et al., 2006; Murray, et al., 2007; Mason & Bakus, 2009). Examples of
interventions that were studied included several pharmacist-delivered patient education
programs, the use of various types of electronic medication dispensing and tracking
devices, telephone reminders, and home visits (Hearnshaw, et al., 2006; Mason & Bakus,
2009; McDonald, Garg, & Haynes, 2002; Murray, et al., 2007).
The most commonly identified measures that produced moderately robust
improvements in adherence were interventions that used more than one teaching modality
in educating patients about their medications (Hu, Juarez, Yeboah, & Castillo, 2014;
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Hugtenburg, Timmers, Elders, Vervloet, & van Dijk, 2013). There was more compelling
evidence for statistically significant improvements in adherence with the use of
interventions using multiple methods and including individualized patient teaching
(Berben, Dobbels, Kugler, Russel, & de Geest, 2011; Kripilani, Yao, & Haynes, 2007;
McDonald, Garg, & Haynes, 2001). In particular, the use of individualized patient
teaching using verbal, written, and illustrated instructions on medications demonstrated
the strongest evidence for use in the clinical setting (Mohan, Riley, Boyington, &
Kripilani, 2013).
Based on this evidence, this scholarly practice project was designed to develop
and implement a process change in the community free clinic setting. The goals were to
incorporate the strongest recommendations found in the literature into a clinical practice
project to improve patient self-efficacy and medication adherence.
Clinical Setting
The clinical setting for this scholarly project is the Community Free Clinic (CFC)
in Huntsville, Alabama. The clinic was established in 1999 by a group of medical
professionals and interested citizens with the goal of providing free health care to
individuals who did not have health insurance coverage and were unable to pay for care.
CFC has operated continuously since 1999, and has been successful in providing quality
healthcare services at no charge to individuals in need in the Huntsville/Madison County
area of North Alabama.
The organizational structure for the CFC is a non-profit entity, governed by a
board of directors under the oversight of a medical director, who is a physician. Daily
clinic operations are managed by the clinic executive director, who oversees the
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volunteer staff, fund-raising activities, budgeting, publicity, and other aspects of the
operation. The clinic is funded through annual grant monies, donations, and fund-raising
events.
In order to avoid duplication of services that are offered by other agencies in the
area, the CFC provides care only to adult patients between the ages of 18 and 65 years of
age. Indigent children in the Madison county area are generally eligible for health
coverage under the Children’s Health Insurance Plan (CHIP), or through Medicaid,
which is funded dually by the federal and state government. Adults aged 65 and older are
eligible for Medicare coverage and thus have access to health care services. Women’s
health services are provided through the county health department and other area
agencies and thus are not included in CFC services. Sexually transmitted infections
(STIs) are managed through another local non-profit agency, therefore STI testing and
treatment is usually not provided through the CFC.
The clinic is staffed by volunteer clerical personnel, nurses, physicians, and nurse
practitioners. The volunteer staff is supplemented by two nurses who are compensated
through the clinic’s operating budget. The primarily volunteer nature of the medical staff
provides a wonderful opportunity for nurses, physicians, and nurse practitioners to
provide a much-needed service to individuals in need. However, it also presents a
challenge in terms of implementation of a true process change in this clinic setting. The
staff mix varies from day to day and, while some individuals volunteer regularly, others
may only be able to do so a few times a year. This factor was taken into consideration in
the planning phase of this project and some adjustments were required to accommodate
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for staff members who were unable to participate in the project because of unfamiliarity
with the usual processes of care.
The clerical volunteers play a vital role in managing patient flow throughout the
clinic and working with patients to complete required forms. A small pharmacy is on-site
and is also staffed by volunteers, many of whom are pharmacy students. This pharmacy
contains a limited supply of specific medications which can be dispensed at the point of
care. This provides a wonderful benefit to patients who may not have the means to get to
a regular pharmacy to pick up medications if they are given prescriptions.
However, because of the limited operating budget under which the clinic operates,
some medications must be written for. Providers try to prescribe medications that are
available at no or very low cost as much as possible. The fact that patients can pick up
medications on site or possibly get them at another pharmacy for free increases the
chances that patients will, indeed, take their prescribed medications.
The clinic is open four days a week and offers multiple services such as a diabetic
education class, individual nutritional counseling, laboratory services, vision screening,
basic dental care, limited psychiatric care and primary care health services. On Tuesday
and Thursday evenings, patients are seen on an appointment-only basis for primary care
management of acute or chronic conditions. Specialized hypertension and diabetes clinics
are also held during the week on an as-needed basis to assist patients with unstable,
progressive disease. The goal is to assist these patients in gaining control over their
disease, thus limiting disease progression and preventing some of the morbidities
associated with these conditions.

7

MEDICATION ADHERENCE PROTOCOL
Free clinic services are offered to patients who demonstrate financial need and the
inability to purchase health insurance. Therefore, proof of income is required. In other
locations in the United States, such community clinics require patients to pay for
services, often on a sliding scale fee schedule. The CFC has opted not to charge patients
for services, as for many clients, even a small surcharge would be difficult for them to
pay. A significant portion of the patient population of the CFC is technically homeless,
meaning that they are living outdoors, staying with friends or family members, or
residing at one of the local shelters.
Individuals who have been incarcerated often seek care at the CFC when they are
released. In the prison system of Alabama and Tennessee, health care is generally wellmanaged. These persons are released with chronic diseases under control for the most
part, thus finding followup care is important in order to maintain disease control through
primary care and pharmacotherapeutic agents as needed. Another cohort of patients
seeking care at the CFC are those persons enrolled in one of the local drug or alcohol
rehabilitation programs. The Huntsville Downtown Rescue Mission and Salvation Army
both have residential rehabilitation programs, meaning patients live on-site until they
complete the program. The CFC serves as a primary care setting for these individuals,
who also often have chronic co-morbidities.
The diverse nature of the patient population and the often complex health care
needs associated with these individuals present unique challenges in the management of
care. A review of 100 medical records at the CFC revealed that the majority of these
patients (80 out of 100) required at least two medications on a long-term basis to manage
chronic medical conditions. Managing medications in the setting of homelessness,
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financial insecurity, substance abuse, or psychiatric co-morbidities is an often
insurmountable barrier for patients. As project director, I also serve as a primary care
provider at the CFC and have worked with this population for over five years. The need
to improve patient adherence to prescribed medications, while at the same time,
increasing individual patient self-efficacy served as the impetus for this project.
Purpose
This clinical project was developed with the goal of improving patient adherence
to prescription medications through the implementation of an evidence-based protocol
utilizing verbal and written and/or illustrated medication instructions. Improved
adherence to prescribed medications leads to improved biophysical and psychosocial
outcomes related to chronic disease management (Granger, et al., 2015). In the setting of
a community free clinic, this evidence-based implementation project had as its’ goals the
improved delivery of patient care along with improved patient outcomes related to
chronic disease management.
Another anticipated benefit of successful implementation of this project, was
decreased medication costs for the CFC. Medications are purchased using limited clinic
funds and improved adherence, it is hoped, will lead to decreased costs related to
medication purchases. Evidence demonstrates that patient outcomes are improved with
medication adherence leading to a decreased need for more medications to manage
complications that may occur as a result of nonadherence (Schroeder, Fahey, & Ebrahim,
2008).
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Conceptual Framework
In terms of clinical interventions to improve patient outcomes, the concept of
patient-centered care has long been considered as central to the provision of effective,
ethical healthcare (Brown & Bussell, 2011) (Costa, Poe, & Lee, 2011). As a profession,
nursing has long espoused the role of patient advocate and has consistently promoted care
that is individualized and based on patient values (Costa, Poe, & Lee, 2011). This
scholarly project was developed in order to promote patient-centered, tailored application
of patent education related to medication adherence based on these core components.
In the mid 1990’s, the term concordance was used in the arena of medication
adherence literature to describe prescribing practices based on a patient-clinician
partnership and collaboration (van den Bemt, Zwikker, & van den Ende, 2012). Using
this concept as a basis for care, patient beliefs and values are the central hub around
which all health management rotates. Concordance, when used to describe a healthcare
concept, leads logically to the idea of self-efficacy which indicates a patient’s own belief
that they can adequately and effectively manage their own health care decisions, in
collaboration with health professionals (Resnick B. , 2014).
Barbara Resnick’s Theory of Self-Efficacy (2014) was utilized as the conceptual
framework for development of this project. This theory, which was derived from
Bandura’s Social Cognitive Theory of Self-Efficacy (1977), conceptualizes environment
and behavior as reciprocal agents in the development of self-efficacy. Although
Bandura’s initial work was in the field of phobias, results from his research indicated that
health behavior change is possible through the use of different methods to increase an
individual’s self-efficacy (Bandura, 1977).
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Two major components of this theory are self-efficacy expectations, or the
individual’s judgment about their personal ability to accomplish something, and outcome
expectations, which are judgments about what will happen if the task is accomplished
(Bandura, 1977). Following Bandura’s initial work, this theory was used in several
studies in order to predict and facilitate health behavior change through environmental
modifications (Curtin, Mapes, Schatel, & Burrows-Hudson, 2005; Duncan, Pozehl,
Norman, & Hertzog, 2011). Another facet of this theory is that individuals may believe
that a certain behavior will bring about a certain outcome, but may not believe that they
are able to accomplish the required behavior (Resnick, 2014).
Although these studies provided further evidence of the value of self-efficacy
development within individual healthcare management, Bandura (1986) recognized that
other factors were intrinsic to this development, such as external constraints, genetic
predisposition, and resource inadequacy. Resnick discussed the need for individuals to
have opportunities to engage in self-evaluation and to compare outcomes with expected
criteria (Resnick, 2013).
The theory of self-efficacy and its’ incorporation into healthcare interventions
must be situation specific (Resnick, 2013). Individual levels of self-efficacy often vary
from one behavior to the next. For example, an individual may have a strong sense of
self-efficacy regarding diet management but a correspondingly low sense of being able to
achieve exercise goals. Therefore, the theory itself calls for a tailored approach to
application. Because this project had as one of its’ goals the development of patient selfefficacy with regard to a particular behavior, medication adherence, the use of this theory
provided a structure within which to develop the specific interventional protocol.

11

MEDICATION ADHERENCE PROTOCOL
This scholarly project incorporated a systems-process change within the clinic
setting to improve education of patients regarding medication administration. Resnick’s
theory served as the foundation for development of the protocol with a focus on
promotion of patient self-efficacy, with a desired outcome of increased patient control
over disease management. Patients participating in the project expressed increased
confidence in managing their medications after receiving individualized teaching and
follow-up regarding adherence.
Sustainability of these gains is an important component of ongoing
implementation of this protocol. Thus, clinic staff have expressed a commitment to
continuing to implement the changes in patient teaching and systems processes.
Methods & Implementation
Development of this protocol began with an extensive review of the literature, as
described earlier. Based on synthesis of literature findings, development was designed to
address factors that could impact patient adherence to medications according to the core
concepts identified in Resnick’s Theory of Self-Efficacy (2014).
Following approval by the Institutional Review Board of the University of
Alabama in Huntsville, project implementation began on November 3, 2015. Clinic staff
members were provided education regarding the project goals, methods, and process
change along with individual components and project timeline.
This medication adherence protocol was developed based on a target population
of adult patients with chronic disease who have been prescribed two or more long-term
medications for disease management. Patients were asked about their willingness to
participate in the project when they arrived at the CFC for scheduled appointments.
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Nursing staff normally perform a triage-assessment consisting of vital signs, finger-stick
blood sugar evaluations, weight, chief complaint, and medication history at the beginning
of each clinic visit.
A preview of medical records of patients scheduled for visits revealed which
patients met the criteria of having two or more prescribed medications. During triage, the
staff nurse asked eligible patients if they would like to participate after fully describing
the project and reading the informed consent form. The benefits and risks were fully
disclosed at this time by the staff nurse. Patients were also advised that participation or
non-participation would not impact the care received at the clinic in a negative manner.
There would be no penalties for not participating. Other important exclusion criteria for
participation included patients who were deemed medically unstable as evidenced by
biophysical instability documented in the medical record, acute complaints at time of
clinic visit, and those who were unable to self-administer their medications.
If the patient agreed to participate and signed the informed consent form, the staff
nurse would discuss current medications with the patient. A semi-scripted dialogue was
used to ask patients about current medication-taking behaviors. This information was
recorded on the Medication Reconciliation Form (Appendix A). This initial medication
assessment included the administration of a simple, subjective patient-self-report on the
number of doses of medication that were missed during the previous week.
Following triage, the patient was then seen by a provider for management of disease
conditions or acute illnesses. During this evaluation, the provider may or may not have
made to the medication regimen. If changes were made, the project director would note
this on the patient record and would add these changes to the patient medication
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schedule. A New Medication Schedule was completed with all prescribed medications
included (Appendix B). Medication teaching, using written, verbal, and illustrated tools
was then provided to the patient prior to discharge and a copy of the illustrated schedule
was given to the patient.
Data was collect on the initial visit and then on the patients’ next follow-up clinic
visit. Medication adherence to individual medications was recorded as a percentage of
medications taken as prescribed. The formula utilized for this calculation is provided
here: 100/x divided by quantity ordered/quantity taken. These percentages were then
averaged to determine a composite adherence score for each patient.
When patients returned for followup visits, their medication schedule and adherence
were reassessed and documented on the Medication Reconciliation Form. Any new
medications or changes in the patient’s medication regimen were added to the illustrated
medication schedule and individualized patient teaching was given regarding the new
medications along with reinforcement of prior teaching regarding all medications.
From these descriptive data, it was determined that, overall, there was an increase in
reported medication adherence behavior following implementation of the new teaching
protocol. Data were based on subjective patient reports of medication adherence, and
there is the possibility that participants in the project may have falsely elevated their
percentage to gain provider approval. This is a concern with most subjective measures of
human behavior and must be considered in terms of data interpretation (Stirratt, et al.,
2015).
Table 1.1 provides a graphic representation of the individual changes in reported
adherence.
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Table 1.1 Medication Adherence Percentage
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As discussed earlier, descriptive statistics were collected and evaluated by
comparing adherence percentages for individual patients. As the table above illustrates,
22 of 30 participants reported improved adherence to prescribed medications following
individualized teaching. Two participants indicated no change in their adherence
percentage, while five participants had a decrease in percentage of medications taken as
prescribed. Overall, patients who participated in the project and received expanded,
individualized patient education demonstrated an improvement in medication adherence
behaviors when compared with initial results.
As evidenced in the literature, many factors impact individual patient adherence
to prescribed medications (McKillop & Joy, 2013). Throughout implementation of this
project, information was gained providing insight into individual characteristics that
impact patient ability to successfully adhere to healthcare recommendations.
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Project Limitations
This scholarly project utilized a subjective assessment of patient medication
adherence. Although this is the simplest and most frequently utilized form of assessing
adherence, self-report of medication-taking behavior is subject to limitations (Stirratt, et
al., 2015). Under-reporting of nonadherence to avoid caregiver disapproval is a concern
(van den Bemt, Zwikker, & van den Ende, 2012). To counter this possibility, clinicians
who provided direct primary care for patients were not involved in administering
assessment questions. Self-report also has a limitation in that it is time-dependent with
recall becoming less accurate after 24-hours (van den Bemt, Zwikker, & van den Ende,
2012). This limitation remained a consideration throughout project implementation and
may have impacted the data collected.
Although direct measurement methods of medication adherence exist, such as
directly observed administration and measurement of serum drug levels, these methods
were not feasible in this setting due to time, cost, and resource availability (Blackberry,
Furler, Best, & Young, 2015). It is important to remember that no method has proven
100% accuracy in determining patient adherence with prescription medications, therefore
fitting the data collection method to the setting is important.
Another limitation is the relatively small number of participants and the limited
time frame for the implementation. Thirty patients were enrolled in the project, which
was implemented from November 3, 2015 through January 31, 2016. As this project was
a process change implementation with the potential for long-term sustainability in this
clinic setting, these limitations were deemed acceptable in terms of the overall project
goals.
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Discussion and Implications for Practice
Throughout implementation of this project, information was gained from patients
which provided insight into individual characteristics that impact self-efficacy relating to
self-administration of medications. Patients, in discussing medication adherence, gave
reasons for not taking their medications as prescribed. Consistent with findings in the
literature, frequently cited reasons were forgetting to take the medication, associated side
effects, and the patients’ perception of whether the medication was ‘working’ (van den
Bemt, Zwikker, & van den Ende, 2012). Based on these observations, future efforts to
improve adherence should focus on addressing problems on an individual basis.
Collaboration between patient and care provider is needed to positively impact
medication adherence in the clinical setting (Barclay, 2009). In considering some of the
other commonly cited reasons for nonadherence, providers, nurses, and patients should
all work together to address these concerns and develop realistic solutions (Aggarwal,
Pender, Mosca, & Mochari-Greenberger, 2015). Recent findings in the literature
demonstrate that there are, indeed, many factors that can impact adherence such as
medical diagnosis and patient gender (Holt, et al., 2013). Cultural factors also play a role,
not only in medication adherence, but healthcare beliefs and practices as a whole (Hu,
Juarez, Yeboah, & Castillo, 2014). Clinicians who provide care for clients with chronic
illness and multiple medications should incorporate what is known about these
differentiating factors into development of evidence-based interventions in the clinical
setting.
An interesting perspective also found in recent literature is that of considering
medication nonadherence as a medical diagnosis (Marcum, Sevick, & Handler, 2013).
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From the authors’ perspective, presenting nonadherence as a diagnosable condition
provides a framework for developing individualized, reimbursable care using the
International Classification of Diseases (ICD) coding in order to bill for services related
to medication adherence management (Marcum, Sevick, & Handler, 2013).
Much of the existing research on medication adherence to date has been done
using diagnosis-specific populations, thus limiting the generalizability of the findings
(Aggarwal, Pender, Mosca, & Machari-Greenberger, 2015; Granger, et al., 2015;
Hearnshaw, et al., 2006; Hu, Juarez, Yeboah, & Castillo, 2014). Further research is
needed based on broader patient populations. By incorporating what we have learned so
far with the results of new research and outcomes from new interventions, we should be
able to positively and consistently assist patients in the development of self-efficacy
regarding medication management.
Some other interesting approaches that are being tested currently include the use
of text messaging reminders about medications, the use of other types of electronic
reminders and medication dispensers as well as telehealth modalities. All of these ideas
have the potential to impact overall rates of medication adherence (Dayer, Heldenbrand,
Anderson, Gubbins, & Martin, 2013). As the culture of the United States, and globally,
becomes increasingly more connected via technology and internet accessibility, this is an
area worth exploring in terms of intervention development. Recent studies have
demonstrated that there are many patients who are interested in technology-based
interventions to help them remember to take their medications as directed (Aggarwal,
Pender, Mosca, & Machari-Greenberger, 2015).
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A final area of discussion is accountability in healthcare. Globally, there is
increasing emphasis on accountability and outcomes in healthcare delivery systems
(Cashin, Chi, Smith, Borowitz, & Thomson, 2014). Clinical interventions that address
patient problems with workable solutions that can easily be incorporated into patient lives
are those which afford the possibility of substantial improvements in patient outcomes
across many healthcare settings. As vital players in this changing healthcare arena, nurse
practitioners and other professionals have a key role in shaping the systems through
which care is delivered through commitment to new discoveries and translation of
evidence to the patient care setting.
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APPENDIX A
MEDICATION RECONCILIATION FORM
Medical Record Number: _________________________________
Staff Signature/Date: _____________________________________
Medication

Reason you

Doses/day on

Number of

Adherence

are taking

prescription?

doses

Percentage

medication?

missed/week?

1.
2.
3.
4.
5.

Comments:
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
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APPENDIX B
NEW MEDICATION SCHEDULE
Patient Name: ___________________________

MR #: _____________________

Staff Signature/Date: ___________________________________________________
Medicine

For?
How
often?

Comments:
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________

22

MEDICATION ADHERENCE PROTOCOL
APPENDIX C
ADHERENCE REPORT FORM
Participant #

Medical Record #

Initial

23

Followup

MEDICATION ADHERENCE PROTOCOL
REFERENCES
(2013). Adherence to long-term therapies: Evidence for Action. The World Health
Organization. Retrieved January 2016, from
http://www.who.int/chp/knowledge/publications/adherence_report/en/index.html.
Aggarwal, B., Pender, A., Mosca, L., & Mochari-Greenberger, H. (2015). Factors
associated with medication adherence among heart failure patients and their
caregivers. Journal of Nursing Education Practice, 5(3), 22-27.
doi:10.5430/jnep.v5n3p22
Bandura, A. (1977). Self-efficacy: Toward a unifying theory of behavioral change.
Psychological Review, 84, 191-215.
Bandura, A. (1986). Social Foundations of Thought and Action. New York: Cambridge
University Press.
Barclay, L. (2009). Policy recommendations may improve medication adherence and
health outcomes. Medscape. Retrieved from
http://www.medscape.com/viewarticle/711431
Berben, L., Dobbels, F., Kugler, C., Russel, C. L., & de Geest, S. (2011). Interventions
used by health care professionals to enhance medication adherence in transplant
patients: A survey of current clinical practice. Progress in Transplantation, 21(4),
322-331.

24

MEDICATION ADHERENCE PROTOCOL
Blackberry, I. D., Furler, J. S., Best, J. D., & Young, D. (2015). Randomized trial of
telephone outreach to improve medication adherence and metabolic control in
adults with diabetes. Diabetes Care, 38. doi:10.2337/dc14-2599
Brown, M. T., & Bussell, J. K. (2011). Medication Adherence: WHO cares? Mayo Clinic
Proceedings, 86(4), 304-314. doi:10.1065/mcp.2010.0575
Cashin, C., Chi, Y.-L., Smith, P., Borowitz, M., & Thomson, S. (Eds.). (2014). Paying
for performance in health care: Implications for health system performance and
accountability. New York: World Health Organization.
Conn, V. S., Ruppar, T. M., Enriquez, M., & Cooper, P. (2015). Medication adherence
interventions that target subjects with adherence problems; Systematic review and
meta-analysis. Research in Social and Administrative Pharmacy.
doi:10.1016/j.sapharm.2015.06.001
Costa, L. L., Poe, S. S., & Lee, M. C. (2011). Challenges in posthospital care: Nurses as
coaches for medication management. Journal of Nursing Care Quality, 243-251.
doi:10.1097/NCQ.obo13e31820e1543
Curtin, R., Mapes, D., Schatell, D., & Burrows-Hudson, S. (2005). Self-management in
patients with end stage renal disease: Exploring domains and dimensions.
Nephrology Nursing Journal, 32(4), 389-395.
Dayer, L., Heldenbrand, S., Anderson, P., Gubbins, P. O., & Martin, B. C. (2013).
Smartphone medication adherence apps: Potential benefits to patients and
providers. Journal of the American Pharmacy Association, 53(2), 172-181.
doi:10.1331/JAPhA.2013.12202
25

MEDICATION ADHERENCE PROTOCOL
Duncan, K., Pozehl, B., Norman, J. F., & Hertzog, M. (2011). A self-directed adherence
management program for patients with heart failure completing combined aerobic
and resistance exercise training. Applied Nursing Research, 24(4), 207-214.
Fu, L., Hu, Y., & Lu, H.-Z. (2015). Overveiws of reveiws on patient compliance with
medication protocols used in highly active antiretroviral therapy. International
Journal of Nursing Sciences, 61-65. doi:10.1016/j.ijns.2015.02.005
Granger, B. B., Ekman, I., Hernandez, A. F., Sawyer, T., Bowers, M. T., DeWald, T. A., .
. . Bosworth, H. B. (2015). Results of the Chronic Heart Failure Intervention to
Improve MEdication study: A randomized intervention in high-risk patients.
American Heart Journal, 539-548. doi:10.1016/j.ahj.2015.01.006
Haynes, R. B., Ackloo, E., Sahota, N., McDonald, H. P., & Yao, X. (2008). Interventions
for enhancing medication adherence. Cochrane Database of Systematic
Reviews(2). doi:10.1002/14651858.CD000011.pub3
Hearnshaw, H., Lindenmeyer, A., Vermeire, E., Van Royen, P., Wens, J., & Biot, Y.
(2006). Interventions to improve adherence to medication in people with type 2
diabetes mellitus: The role of nurses. European Diabetes Nursing, 3(2), 73-77.
Holt, E., Joyce, C., Dornelles, A., Morisky, D., Webber, L. S., Muntner, P., & KrouselWood, M. (2013). Sex differences in barriers to antihypertensive medication
adherence: Findings from the Cohort Study of Medication Adherence among
Older Adults (CoSMO). Journal of the American Geriatric Society, 61(4), 558564. doi:10.11111/jgs.12171

26

MEDICATION ADHERENCE PROTOCOL
Hu, D., Juarez, D. T., Yeboah, M., & Castillo, T. P. (2014). Interventions to increase
medication adherence in African-American and Latino populations: A literature
review. Hawaii Journal of Medicine & Public Health, 73(1), 11-18.
Hugtenburg, J. G., Timmers, L., Elders, P. J., Vervloet, M., & van Dijk, L. (2013).
Definitions, variants, and causes of nonadherence with medication: A challenge
for tailored interventions. Patient Preference and Adherence, 7, 675-682.
Kripalani, S., Yao, X., & Haynes, B. (2007). Interventions to enhance medication
adherence in chronic medical conditions. Archives of Internal Medicine, 167, 540550.
Kronish, I. M., & Ye, S. (2013). Adherence to cardiovascular medications: Lessons
learned and future directions. Progressive Cardiovascular Disease, 55(6), 590600. doi:10.1016/j.pcad.2013.02.001
Mancuso, C., Rincon, M., McCulloch, C., & Charlson, M. (2001). Self-efficacy,
depressive symptoms, and patients' expectations predict outcomes in asthma.
Medical Care, 1326-1338.
Marcum, Z. A., Sevick, M. A., & Handler, S. M. (2013). Medication nonadherence: A
diagnosable and treatable medical condition. Journal of the American Medical
Association, 309(20), 2105-2106. doi:10.1001/jama.2013.4638
Mason, N., & Bakus, J. L. (2009). Strategies for reducing polypharmacy and other
medication-related problems in chronic kidney disease. Seminars in Dialysis, 5561.

27

MEDICATION ADHERENCE PROTOCOL
McDonald, H. P., Garg, A. X., & Haynes, R. B. (2002). Interventions to enhance patient
adherence to medication prescriptions. Journal of the American Medical
Association, 288(22), 2868-2879.
McKillop, G., & Joy, J. (2013). Patients' experience and perceptions of polypharmacy in
chronic kidney disease and its impact on adherent behavior. Journal of Renal
Care, 200-207.
Meyer, J. P., Moghimi, Y., Marcus, R., Lim, J. K., Litwin, A. H., & Altice, F. L. (2015).
Evidence-based interventions to enhance assessment, treatment, and adherence in
the chronic hepatitis C care continuum. International Journal of Drug Policy,
922-935. doi:10.1016/j.drugpo.2015.05.002
Michalets, E., Creger, J., & Shillinglaw, W. (2015). Outcomes of expanded use of clinical
pharmacist practitioners in addition to team-based care in a community health
system intensive care unit. American Journal of Health Systems Pharmacists, 72,
47-53. doi:10.2146/ajhp140105
Mohan, A., Riley, B., Boyington, D., & Kripalani, S. (2013). Illustrated medication
instructions as a strategy to improve medication management among Latinos: A
qualitative analysis. Journal of Health Psychology, 18(2), 187-197.
doi:10.1177/1359105312440300
Morgan, C., McBeth, J., Cordingley, L., Watson, K., Hyrich, K. L., Symmons, D. P., &
Bruce, I. N. (2015). The influence of behavioural and psychological factors on
medication adherence over time in rheumatoid arthritis patients: A study in the
biologics era. Rheumatology, 1-12. doi:10.1093/rheumatology/kev105
28

MEDICATION ADHERENCE PROTOCOL
Murray, M. D., Young, J., Hoke, S., Tu, W., Weiner, M., Morrow, D., . . . Brater, D. C.
(2007). Pharmacist intervention to improve medication adherence in heart failure.
Annals of Internal Medicine, 146, 714-725.
Resnick, B. (2013). Self-Efficacy. In S. J. Peterson, & T. S. Bredow (Eds.), Middle
Range Theories: Application to Nursing Research (3rd ed., pp. 82-95).
Philadelphia: Wolters Kluwer Health Lippincott Williams & Wilkins.
Resnick, B. (2014). Theory of Self-Efficacy. In M. J. Smith, & P. R. Liehr (Eds.), Middle
Range Theory for Nursing (3rd ed., pp. 197-223). New York: Springer Publishing
Company.
Sandberg-Cook, J. (2014). Aging and common geriatric syndromes. In T. Buttaro, J.
Trybulski, P. P. Bailey, & J. Sandberg-Cook (Eds.), Primary Care: A
Collaborative Practice (4th ed., pp. 71-79). St. Louis: Elsevier Mosby.
Schroeder, K., Fahey, T., & Ebrahim, S. (2008). Interventions for improving adherence to
treatment in patients with high blood pressure in ambulatory settings: review. The
Cochrane Collaboration, 1-31.
Spoelstra, S. L., Given, C. W., Sikorskii, A., Coursaris, C. K., Majumder, A.,
DeKoekkoek, T., . . . Given, B. A. (2015). A randomized controlled trial of the
feasibility and preliminary efficacy of a texting intervention on medication
adherence in adults presecribed oral anti-cancer agents: Study protocol. Journal of
Advanced Nursing, 1-12.
Stirratt, M. J., Dunbar-Jacob, J., Crane, H., Simoni, J. M., Czajkowski, S., Hilliard, M. E.,
. . . Nilsoen, W. J. (2015). Self-report measures of medication adherence
29

MEDICATION ADHERENCE PROTOCOL
behavior: Recommendations on optimal use. TBM, 5, 470-482.
doi:10.1007/s13142-015-0315-2
van den Bemt, B. J., Zwikker, H. E., & van den Ende, C. H. (2012). Medication
adherence in patients with rheumatoid arthritis: A critical appraisal of the existing
literature. Expert Review in Clinical Immunology, 8(4), 337-351.
doi:10.1586/ECI.12.23
Wilper, A., Woolhandler, S., Lasser, K., McCormick, D., Bor, D., & Himmelstein, D.
(2008). A national study of chronic disease prevalence and access to care in
uninsured U.S. adults. Annals of Internal Medicine, 149(3), 170-176.
Zullig, L. L., Peterson, E. D., & Bosworth, H. B. (2013). Ingredients of successful
interventions to improve medication adherence. Journal of the American Medical
Association, e1-e2. doi:10.1001/jama.2013.282818

30

MEDICATION ADHERENCE PROTOCOL
RESOURCES

Asante, E. (2013). Interventions to promote treatment adherence in type 2 diabetes
mellitus. British Journal of Community Nursing, 18(6), 267-274.
Clyne, W., White, S., & McLachlan, S. (2012). Developing consensus-based policy
solutions for medicines adherence for Europe: A delphi study. BMC Health
Services, 12(425). doi:10.1186/1472-6963-12-425
Cutrona, S. L., Choudhry, N. K., Fischer, M. A., Servi, A., Liberman, J. N., Brennan, T.,
& Shrank, W. H. (2010). Modes of delivery for interventions to improve
cardiovascular medication adherence: Review. Americal Journal of Managed
Care, 16(12), 929-942.
Franklin, J. M., Shrank, W. H., Pakes, J., Sanfelix-Gimeno, G., Matlin, O. S., Brennan, T.
A., & Choudhry, N. K. (2013). Group-based trajectory models: A new approach
to classifying and predictin long-term medication adherence. Medical Care, 51(9),
789-796.
Gatwood, J., & Erickson, S. R. (2010, December). Medication adherence: The search for
interventions that work. American Journal of Managed Care, 16(12), 925-926.
Gwadry, F. H., Manias, E., Lal, L., Salas, M., Hughes, D. A., Ratzki-Leewing, A., &
Grubisic, M. (2013). Impact of interventions on medication adherence and blood
pressure control in patients with essential hypertension: A systematic review by
the ISPOR medication adherence and persistence special interest group. Value in
Health, 16, 863-871. Retrieved from http://dx.doi.org/10.1016/j.jval.2013.03.1631
31

MEDICATION ADHERENCE PROTOCOL
Hacihasanoglu, R., & Gozum, S. (2011). The effect of patient education and home
monitoring on medication compliance, hypertension management, healthy
lifestyle behaviours and BMI in a primary health care setting. Journal of Clinical
Nursing, 20, 692-705. doi:10.1111/j.1365-2702.2010.03534.x
Haynes, R. B., McDonald, H. P., & Garg, A. X. (2002). Helping patients follow
prescribed treatment: Clinical applications. Journal of the American Medical
Association, 288(22), 2880-2883. doi:10.1001/jama.288.22.2880
Houts, P. S., Doak, C. C., Doak, L. G., & Loscalzo, M. J. (2006). The role of pictures in
improving health communication: A review of research on attention,
comprehension, recall, and adherence. Patient Education and Counseling, 173190.
Kalogianni, A. (2012). Can nursing interventions increase adherence medication
regimen? Health Science Journal, 6(1), 1-3.
Katz, M. G., Kripilani, S., & Weiss, B. D. (2006). Use of pictorial aids in medication
instructions: A review of the literature. American Journal of Health-Systems
Pharmacy, 63, 2391-2397. doi:10.2146/ajhp060162
Khanna, R., Pace, P. F., Mahabaleshwarkar, R., Basak, R. S., Datar, M., & Banahan, B.
F. (2012). Medication adherence among recipients with chronic diseases enrolled
in a state Medicaid program. Population Health Management, 15(5), 253-260.
doi:10.1089/pop.2011.0069
Kripilani, S., Robertson, R., Love-Ghaffari, M. H., Henderson, L. E., Praska, J.,
Strawder, A., . . . Jacobson, T. A. (2007). Development of an Illustrated
32

MEDICATION ADHERENCE PROTOCOL
Medication Schedule as a Low-lieracy Patient Education Tool. Patient Education
and Counseling, 368-377. doi:10.1016/j.pec.2007.01.020
Kripilani, S., Schmotzer, B., & Jacobson, T. A. (2012). Improving medication adherence
through graphically enhanced interventions in coronary heart disease (IMAGECHD): A randomized controlled trial. Journal of General Internal Medicine,
27(12), 1609-1617. doi:10.1007/s11606-012-2136.z
Lee, J. K., Grace, K. A., & Taylor, A. J. (2006). Effect of a pharmacy care program on
medication adherence and persistence, blood pressure, and low-density
lipoprotein cholesterol. Journal of the American Medical Association, 296, E1E9. doi:10.1001/jama.296.21.joc60162
Nieuwlaat, R., Wilczynski, N., Navarro, T., Hobson, N., Jeffery, R., Keepanasseril, A., . .
. Haynes, R. (2014). Interventions for enhancing medication adherence. Cochrane
Database of Systematic Reviews(11). doi:10.1002/14651858.CD000011.pub4
Ogedegbe, G. O., Boutin-Foster, C., Wells, M. T., Allegrante, J. P., Isen, A. M., Jobe, J.
B., & Charlson, M. E. (2012). A randomized controlled trial of positive-affect
intervention and medication adherence in hypertensive African Americans.
Archives of Internal Medicine, 172(4), 322-326.
doi:10.1001/archinternmed.2011.1307
Okpataku, C., Kwanashie, H., Ejiofor, J., & Olisah, V. (2015). Medication compliance
behavior in psychiatric out-patients with psychoactive substance use comorbidity
in a Nigerian tertiary hospital. Nigerian Journal of Clinical Practice, 18(3), 371376. doi:10.4103/1119-3077.151753
33

MEDICATION ADHERENCE PROTOCOL
Ornstein, S., Nietert, P. J., Jenkins, R. G., & Litvin, C. B. (2013). The Prevalence of
Chronic Diseases and Multimorbidity in Primary Care Practice: A PPRNet
Report. Journal of the American Board of Family Medicine, 518-24.
Osborn, C. Y., Cavanaugh, K., Wallston, K. A., Kripalani, S., White, R. O., Elasy, T. A.,
& Rothman, R. L. (2011). Health literacy explains racial disparities in diabetes
medication adherence. Journal of Health Community, 16, 268-278.
doi:10.1080/10810730.2011.604388
Osterberg, L., & Blaschke, T. (2005). Adherence to medication. New England Journal of
Medicine, 353(5), 487-497.
Rimando, M. (2013). Factors influencing medication compliance among hypertensive
older African American adults. Ethnicity & Disease, 23, 469-473.
Rolnick, S. J., Pawloski, P. A., Hedblom, B. D., Asche, S. E., & Bruzek, R. J. (2013).
Patient characteristics associated with medication adherence. CM & R.
doi:10.3121/cmr.2013.1113
Roumie, C. L., Greevy, R., Wallston, K. A., Elasy, T. A., Kaltenbach, L., Kotter, K., . . .
Speroff, T. (2011). Patient centered primary care is associated with patient
hypertension medication adherence. Journal of Behavioral Medicine, 34, 244253. doi:10.1007/s10865-010-9304-6
Sabate', E. (2003). Adherence to long-term therapies: Evidence for action. World Health
Organization. Retrieved July 2015, from
http://www.who.int/chp/knowledge/publications/adherence_report/en

34

MEDICATION ADHERENCE PROTOCOL
Simpson, R. (2006). Challenges for improving medication adherence. Journal of the
American Medical Association, 2614-2616.
van Dulmen, S., Sluijs, E., van Dijk, L., de Ridder, D., Heerdink, R., & Bensing, J.
(2007). Patient adherence to medical treatment: a review of reviews. BMC Health
Services Research, 7(55), 1-13. doi:0.86/472-6963-7-55
van Mierlo, T., Fournier, R., & Ingham, M. (2015, June). Targeting medication nonadherence behavior in selected autoimmune diseases: A systematic approach to
digital health program development. PLOS ONE, 1-17.
doi:10.1371/journal.pone.0129364
Viswanathan, M., Golin, C. E., Jones, C. D., Ashok, M., Blalock, S. J., Wines, R. C., . . .
Lohr, K. N. (2012). Interventions to Improve Adherence to Self-Administered
Medications for Chronic Diseases in the United States. Annals of Internal
Medicine, 785-795.
Williams, A., Manias, E., & Walker, R. (2008). Interventions to improve medication
adherence in people with multiple chronic conditions: A systematic review.
Journal of Advanced Nursing, 63(2), 132-143. doi:10.1111/j.13652648.2008.04656.x
Wolf, M. S., Curtis, L. M., Waite, K., Bailey, S. C., Hedlund, L. A., Davis, T. C., . . .
Wood, A. J. (2011, February 28). Helping patients simplify and safely use
complex prescription regimens. Archives of Internal Medicine, 171(4), 300-310.

35

MEDICATION ADHERENCE PROTOCOL

36

